China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.
| 11.72 | |
| 12.28 | |
| - | |
| 12.34 | |
| 11.7 | |
| 9.47-13.88 | |
| 18 414 M | |
| 20.5167 | |
| 1 496 M | |
| 35 127 M | |
| 0.03 | |
| 0.136 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Shares of Chinese pharmaceutical companies plunged Tuesday morning on Chinese bourses, continuing a slide that began in the face of competition from Pfizer's COVID-19 drug Paxlovid earlier this month. Continue reading
(Bloomberg) -- Pfizer Inc. clinched an agreement to sell its antiviral medication Paxlovid in China through a state-owned company, making the drug available to battle surging Covid-19 cases. Most Rea...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
